title: Rotigotine transdermal system for perioperative administration.
abstract: We present a series of patients participating in clinical trials with the rotigotine transdermal system. All patients were scheduled for surgery with general anaesthesia unrelated to the trial procedure or to rotigotine. Perioperative administration of rotigotine appeared to be feasible and efficacious. No safety issues emerged from these observations.
authors.affiliation: Tel-Aviv University Medical School, Ramat-Aviv, Israel. neuro13@post.tau.ac.il
authors.forename: A D
authors.initials: AD
authors.lastname: Korczyn
authors.forename: H
authors.initials: H
authors.lastname: Reichmann
authors.forename: B
authors.initials: B
authors.lastname: Boroojerdi
authors.forename: H-J
authors.initials: HJ
authors.lastname: Häck
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000369:Aged, 80 and over; D000768:Anesthesia, General; D018491:Dopamine Agonists / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D019990:Perioperative Care; D016032:Randomized Controlled Trials as Topic; D013514:Surgical Procedures, Operative; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D018491:Dopamine Agonists; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine